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Purpose: This study provides descriptive epidemiological data, such as the percentage of cases 
diagnosed, crude incidence rate (CIR), and age-standardized incidence rate (ASIR) of ovarian 
cancer in Saudi Arabia from 2001–2008. 
Patients and methods: A retrospective descriptive epidemiological analysis of all ovarian 
cancer cases recorded in the Saudi Cancer Registry (SCR) from January 2001–December 2008 
was performed. The data were analyzed using descriptive statistics, analysis of variance tests, 
Poisson regression, and simple linear modeling.
Results: A total of 991 ovarian cancer cases were recorded in the SCR from January 2001–De-
cember 2008. The region of Riyadh had the highest overall ASIR at 3.3 cases per 100,000 women, 
followed by the Jouf and Asir regions at 3.13 and 2.96 cases per 100,000 women.  However, Hail 
and Jazan had the lowest rates at 1.4 and 0.6 cases per 100,000 women, respectively. Compared 
to Jazan, the incidence rate ratio for the number of ovarian cancer cases was significantly higher 
(P,0.001) in the Makkah region at 6.4 (95% confidence interval [CI]: 4.13–9.83), followed 
by Riyadh at 6.3 (95% CI: 4.10–9.82), and the eastern region of Saudi Arabia at 4.52 (95% CI: 
2.93–6.98). The predicted annual CIR and ASIR for ovarian cancer in Saudi Arabia could be 
defined by the equations 0.9 + (0.07× years) and 1.71 + (0.09× years), respectively.
Conclusion: We observed a slight increase in the CIRs and ASIRs for ovarian cancer in Saudi 
Arabia from 2001–2008. Riyadh, Jouf, and Asir had the highest overall ASIR, while Jazan and 
Hail had the lowest rates. Makkah, Riyadh, and the eastern region of Saudi Arabia had the high-
est incidence rate ratio for the number of ovarian cancer cases. Further analytical studies are 
required to determine the potential risk factors of ovarian cancer among Saudi women.
Keywords: cancer epidemiology, ovarian cancer, Saudi Cancer Registry, incidence rate
Introduction
Ovarian cancer is the eighth most common type of cancer among women in the world. 
Furthermore, it is the seventh leading cause of cancer-related mortality with a severe 
impact on socioeconomic and community health, globally.1–4 Compared to other types 
of gynecologic malignancies, ovarian cancer has the highest mortality rate in developed 
countries worldwide.5–7 The American Cancer Society estimated that 22,240 women 
were going to be diagnosed with ovarian cancer in the US in 2013, while the number 
of ovarian cancer-related deaths was estimated to be 14,230.8 Moreover, ovarian cancer 
was estimated to account for 3% of all cancers among women. Currently, the lifetime 
International Journal of Women’s Health 2014:6submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
640
alghamdi et al
risk of developing ovarian cancer is approximately 1 in 
72, while the lifetime risk of dying from ovarian cancer is 
approximately 1 in 100.8
The International Agency for Research on Cancer 
estimated that the age-standardized incidence rate (ASIR) 
and the age-standardized mortality rate for ovarian cancer 
in Saudi Arabia in 2012 was 3.4 per 100,000 women and 
2.5 per 100,000 women, respectively.9 Furthermore, the 
registry of the King Faisal Specialist Hospital and Research 
Centre (2011) recorded 1510 cases of ovarian cancer with 
admission to the hospital from 1975–2011.10 In 2008, data 
from the Saudi Cancer Registry (SCR) suggested that ovar-
ian cancer ranked seventh in cancer incidence among Saudi 
women.11 The ASIR of ovarian cancer in Saudi Arabia 
is low in comparison with other countries in the Arabian 
Gulf. For example, in 2012, the reported ASIR of ovarian 
cancer for Oman, United Arab Emirates, Kuwait, Qatar, and 
Bahrain was 10.2, 6.4, 4.7, 4.6, and 4.4 per 100,000 women, 
respectively.9
Despite a lack of data on the geographic distribution of 
ovarian cancer among women in Saudi Arabia, we aimed to 
investigate and describe the crude incidence rate (CIR) and 
ASIR of ovarian cancer cases by providing an observational 
descriptive epidemiological analysis of cancer of the ovary 
while considering spatial/temporal distribution of recorded 
cases in the SCR from 2001–2008.12
Materials and methods
A retrospective descriptive epidemiological study of the 
ovarian cancer cases and diagnosed in Saudi Arabia from 
January 2001–December 2008 was performed. The data of 
reports regarding cancer incidence in Saudi Arabia are pub-
licly available and easily accessible to be downloaded from 
the website of SCR. The main mission of SCR is to gather, 
register, and provide high standard data for cancer incidence 
stratified by region, age group, and year of diagnosis. Fur-
thermore, the published reports by SCR would be available 
to policy makers, cancer researchers, treating physician, 
cancer control, and prevention programs. Therefore, no ethi-
cal approval was required for this observational descriptive 
epidemiological study. The data source for this study was 
the SCR, a population-based registry established in 1992 by 
the Ministry of Health of Saudi Arabia. The data cannot be 
obtained directly from the SCR, but it is published in reports. 
However, no data was available from 1994–2000 and the lat-
est published report of the SCR was available in 2008.
Since 2001, the SCR has been providing reports on 
the patterns of cancers in Saudi Arabia with the primary 
objective of defining the population-based incidence of the 
disease. Currently, there are comprehensive reports for each 
of the 13 administrative regions of Saudi Arabia. Each report 
 discusses the number and percentage of cases diagnosed, the 
CIR, and the ASIR (adjusted by region and year of diagnosis) 
of cancer from 2001–2008. The current study utilized the 
SCR reports to gather all the information on ovarian cancer 
with the aim of presenting the descriptive epidemiology of 
ovarian cancer in Saudi Arabia.
Data were analyzed using the Statistical Package for the 
Social Sciences version 20.0 (IBM Corporation, Armonk, 
NY, USA). The descriptive analysis of the epidemiological 
data of ovarian cancer was performed by calculating the 
overall percentage of ovarian cancer cases, CIR, and the 
ASIR adjusted by the age group, region, or year of diagnosis. 
The analysis of variance (ANOVA) test was performed to 
determine the effect of the geographical area and the year 
of diagnosis on CIR and ASIR.13 Simple linear regression 
was used separately with an independent variable (year of 
diagnosis) to predict the annual CIR and the ASIR of ovar-
ian cancer among Saudi women.14 In addition, the Poisson 
regression was conducted to calculate the incidence rate 
ratio (IRR) of ovarian cancer cases for each region of Saudi 
Arabia.
Results
A total of 991 ovarian cancer cases were recorded in the 
SCR from January 2001–December 2008. The percent-
age of women diagnosed with ovarian cancer increased 
slightly from 2001–2008. Figure 1A and B shows that 
there were 101 new ovarian cancer cases in 2001 (3.7% 
of all cancer cases diagnosed in women; 95% confidence 
interval [CI]: 1.7%–5.7%) and 96 in 2002. This indicates 
a 0.4% decline in cases. By 2005, 136 ovarian cancer 
cases were reported, corresponding to a 0.2% increase. 
The number of ovarian cancer cases diagnosed annually 
remained slightly high, but the percentages were stable 
in 2005 and 2008 at 3.5%.
The average number and percentage of ovarian cancer 
cases diagnosed from 2001–2008, adjusted by age group, 
was calculated using the data from the SCR (Table 1 and 
Figure 1C). Women aged 45–59 years were most fre-
quently diagnosed with ovarian cancer followed by those 
aged 60–74 years, representing 31% (38 cases) and 26.0% 
(33 cases) of the total number of ovarian cancer cases. In 
contrast, the younger (0–44 years) and older (75 years and 
over) groups recorded the lowest overall number and per-
centage of cases.
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The CIRs per 100,000 women, adjusted for the year of 
diagnosis, indicated a steady increase in ovarian cancer cases 
in Saudi Arabia from 2001–2008. As shown in Table 2 and 
Figure 2A, a CIR of 1.3 (95% CI: 0.6–2.0) ovarian cancer 
cases per 100,000 women was estimated in 2001; and a 
CIR of 1.8 (95% CI: 0.9–2.7) cases per 100,000 women in 
2008. The latter CIR was the highest rate observed, but it 
was not statistically significantly different compared to the 
other years (F[7, 96]=0.106; P.0.05). Linear regression 
analysis suggested that the annual increase of CIR for ovar-
ian cancer in Saudi Arabia can be predicted by the equation 
0.9 + (0.07× years), which indicates that the CIR of ovarian 
cancer increased on average by 0.9 cases per 100,000 Saudi 
women per year.
Table 3 and Figure 2B show the overall CIR of ovarian 
 cancer per 100,000 women, adjusted for the region of Saudi 
Arabia from 2001–2008. The region of Riyadh had the highest 
overall CIR for ovarian cancer at 1.9 (95% CI: 1.6–2.2) cases per 
100,000 women, followed by the regions of Baha and  Makkah 
at 1.8 (95% CI: 1.0–2.6) and 1.7 (95% CI: 1.4–3.0) cases per 
100,000 women, respectively. The ANOVA test revealed 
that the incidence rates of ovarian cancer were significantly 
180 3.8
3.7
3.6
3.5
3.4
3.3
3.2
3.1
%
 o
f 
ca
se
s
3
2.9
2.8
A B
C
160
140
120
100
80
40
60N
u
m
b
er
 o
f 
ca
se
s
20
0
50
45
40
35
M
ea
n
30
25
20
15
10
5
Number of cases
15–290–14
%
30–44
Age groups
45–59 60–74 ≥75
2001 2002 2003
Year of diagnosis
2004 2005 2006 2007 2008 2001 2002 2003
Year of diagnosis
2004 2005 2006 2007 2008
Figure 1 number and percentage of ovarian cancer cases (A and B) in saudi arabia from 2001–2008. Overall number and percentage of ovarian cancer cases’ distribution 
by age group (C) in saudi arabia from 2001–2008.
Table 1 Ovarian cancer cases distribution by age group in saudi arabia from 2001–2008
Year Age group of ovarian cancer
0–14 15–29 30–44 45–59 60–74 $75 Total
# % # % # % # % # % # % Total % of total
2001 4 4 15 14.8 17 16.8 31 30.7 21 20.8 13 12.9 101 3.7
2002 6 6 15 16 13 14 29 30 24 25 9 9 96 3.3
2003 4 4 14 12.8 18 16.5 33 30 26 23.9 14 12.8 109 3.4
2004 6 6 11 10 22 20 32 30 27 25 10 9 108 3.1
2005 8 6 17 12.5 18 13 39 29 40 29.5 14 10 136 3.5
2006 2 2 15 11 22 17 44 33 38 29 11 8 132 3.2
2007 10 6.7 19 12.8 25 17 47 31.5 36 24 12 8 149 3.1
2008 6 3.7 17 10.6 22 13.7 51 32 50 31 14 9 160 3.5
average 6 5 15 13 20 16 38 31 33 26 12 9.8 123.9 3.4
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higher for these three regions  compared to the other regions 
of Saudi Arabia (F[12, 91]=4.988; P,0.001).  Furthermore, 
Jazan (95% CI: 0.1–0.5), Najran (95% CI: 0.3–1.3), and the 
northern region of Saudi Arabia (95% CI: 0.3–1.3) had the low-
est average CIRs for ovarian cancer at 0.3, 0.8, and 0.8 cases 
per 100,000 women, respectively.
The overall ASIRs per 100,000 women were calculated 
for all of the SCR reports on the basis of (Segi) world standard 
for intermediate-age populations (Table 4). This standard can 
be used in the direct method of standardization to calculate 
the ASIR. It allows to control the confounding effects of 
age when making a comparison between  populations with 
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Figure 2 cIr and asIr of ovarian cancer cases (A) in saudi arabia from 2001–2008. Overall cIr and asIr of ovarian cancer cases’ distribution by region (B) in saudi arabia 
from 2001–2008.
Abbreviations: cIr, crude incidence rate; asIr, age standardized incidence rate.
Table 2 cI for %, cIr, and asIr of ovarian cancer cases in saudi 
arabia from 2001–2008
Year Percentage CIR  
per 100,000
ASIR  
per 100,000
% 95% CI CIR 95% CI ASIR 95% CI
2001 3.7 1.7–5.7 1.3 0.6–2.0 2.3 1.3–3.3
2002 3.3 1.5–4.8 1.2 0.5–1.9 2.0 1.0–3.0
2003 3.4 1.6–5.0 1.4 0.7–2.2 2.0 0.9–3.1
2004 3.1 0.6–3.7 1.3 0.4–1.7 2.2 1.4–3.0
2005 3.5 0.8–4.3 1.6 0.7–2.5 2.8 2.0–3.6
2006 3.2 0.7–3.9 1.5 0.5–2.5 2.8 1.9–3.7
2007 3.1 0.8–3.9 1.7 1.0–2.4 2.6 1.8–3.4
2008 3.5 1.3–4.8 1.8 0.9–2.7 3.0 2.3–3.7
Overall 3.4 1.1–4.5 1.5 0.6–2.2 2.5 1.5–3.3
Note: Values in bold denote there are no significant differences between years of 
diagnosis, P-value .0.05.
Abbreviations: cIr, crude incidence rate; asIr, age-standardized incidence rate; 
CI, confidence interval.
Table 3 cI for overall percentage, cIr, and asIr of ovarian 
cancer cases in the regions of saudi arabia from 2001–2008
Regions Overall 
percentage
Overall CIR Overall ASIR
% 95% CI CIR 95% CI ASIR 95% CI
asir 3.8 2.6–5.0 1.3 0.8–1.8 2.96 1.25–2.66
Baha 5.0 3.4–6.6 1.8 1.0–2.6 2.28 1.32–3.25
Jazan 1.6 0.5–2.7 0.3 0.1–0.5 0.57 0.17–0.97
Madinah 3.7 2.5–4.9 1.3 1.0–1.6 2.27 1.67–2.87
Hail 3.4 1.8–5.0 1.0 0.5–1.5 1.35 0.70–1.99
Qassim 2.3 1.2–3.4 0.9 0.3–1.5 1.46 0.69–2.23
riyadh 3.4 3.1–3.7 1.9 1.6–2.2 3.30 2.68–3.91
Makkah 3.6 3.1–4.1 1.7 1.4–2.0 2.81 2.20–3.42
najran 3.1 1.0–5.2 0.8 0.3–1.3 1.92 0.52–3.32
Jouf 4.8 1.4–8.2 1.4 0.7–2.1 3.13 1.50–4.76
Tabuk 3.0 2.5–3.5 1.1 0.8–1.4 2.35 1.51–3.18
eastern region 3.2 2.6–3.8 1.6 1.3–1.9 2.92 2.39–3.45
northern  
region
2.6 0.7–4.5 0.8 0.3–1.3 1.55 0.24–2.85
Note: Values in bold denote for CIR, Riyadh, Baha and Makkah were significantly 
higher than other regions of saudi arabia, P-value ,0.05; for asIr, riyadh, Jouf and 
Asir were significantly higher than other regions of Saudi Arabia, P-value ,0.05.
Abbreviations: CI, confidence interval; CIR, crude incidence rate; ASIR, age-
standardized incidence rate.
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different age structures.15,16 Therefore, the ASIR of  ovarian 
cancer per 100,000 women, adjusted for the year of diag-
nosis in Saudi Arabia, from 2001–2008, is displayed in 
Table 2 and Figure 2A. The SCR reports indicated a slight 
increase in the number of cases of ovarian cancer diagnosed 
from 2001–2008, with the highest ASIR of three cases per 
100,000 women recorded in 2008 (95% CI: 2.3–3.7). Linear 
regression showed that the annual increase in ASIR of ovar-
ian cancer in Saudi Arabia can be predicted by the equation 
1.71 + (0.09× years), which suggests that the ASIR of ovarian 
cancer increased by a predicted average of 0.09 cases per 
100,000 women per year. Furthermore, Riyadh had the high-
est overall ASIR for ovarian cancer at 3.3 (95% CI: 2.68–3.91) 
cases per 100,000 women, followed by Jouf and Asir at 3.13 
(95% CI: 1.5–4.76) and 2.96 (95% CI: 1.25–2.66) cases per 
100,000 women, respectively (Table 3 and Figure 2B). The 
ANOVA test indicated that the ASIRs of ovarian cancer were 
significantly higher for these three regions compared to other 
provinces of Saudi Arabia (F[12, 91]=4.100; P,0.001). Fur-
thermore, Jazan, Najran, and the northern region of Saudi 
Arabia had the lowest average ASIRs for ovarian cancer at: 
0.3 (95% CI: 0.1–0.5); 0.8 (95% CI: 0.3–1.3); and 0.8 (95% 
CI: 0.3–1.3) cases per 100,000 women, respectively.
The Poisson regression was conducted to calculate 
the IRR of ovarian cancer cases for the different regions 
of Saudi  Arabia. The model was statistically significant 
(LRχ2[15]=850.6; P,0.001). As shown in Table 5, Jazan 
was used as the reference region for comparing the other 
provinces of Saudi Arabia. The IRRs were significantly higher 
(P,0.001) for Makkah at 6.4 (95% CI, 4.12–9.83), Riyadh at 
6.3 (95% CI, 4.10–9.82), and the eastern region of Saudi Arabia 
at 4.52 (95% CI, 2.93–6.98).
The differences in the CIRs and ASIRs between 
2001–2008 were calculated to investigate the pattern of 
ovarian cancer in the different regions of Saudi Arabia 
(Table 6). The greatest changes in percentages and rates 
were observed in the region of Baha (6.4%; CIR, 2.9; 
ASIR, 3.6). However, the CIR and ASIR for all regions, 
with the exception of Baha, were under the predicted values 
based on the equations for the linear regression, ie, 0.9 + 
(0.07×8 years) = 1.46 per 100,000 women for the CIR and 
2.43 + (0.09×8 years) = 2.43 per 100,000 women for the ASIR. 
The smallest changes in the CIR and ASIR were observed 
in the regions of Najran (−5.8%, −1.3 CIR, −4.1 ASIR), and 
Hail (−2.9%; CIR, −0.5; ASIR, −1.1). The  percentage of 
ovarian cancer cases decreased by 5.8% and 2.9% in Najran 
and Hail,  respectively.  Furthermore, in the Najran region the 
CIR and ASIR decreased by 1.3 and 4.1 cases per 100,000 
women, respectively; whereas, in the Hail region the CIR 
decreased by 0.5 case and the ASIR decreased by 1.1 cases 
per 100,000 women. However, these data indicate downtrend-
ing rates for both regions from 2001–2008.
Discussion
Ovarian cancer is an important malignancy in women with 
regards to its incidence and mortality. The current study 
Table 5 Poisson regression model to calculate the Irr and check 
if there is an effect due to geographical area
# casesa IRR P-value 95% CI
Regions
 1. asir 0.55 0.06 0.34–0.87
 2. Baha 2.56 0.05* 1.56–3.98
 3. Jazan 1 referenceb
 4. Madinah 2.21 0.08 1.39–3.50
 5. Hail 0.76 0.23 0.49–1.18
 6. Qassim 1.21 0.40 0.77–1.91
 7. riyadh 6.3 0.001* 4.10–9.82
 8. Makkah 6.4 0.001* 4.12–9.83
 9. najran 0.50 0.09 0.32–0.81
10. Jouf 0.48 0.12 0.30–0.76
11. Tabuk 0.98 0.60 0.64–1.51
12. eastern region 4.52 0.001* 2.93–6.98
13. northern region 0.44 0.10 0.26–0.62
Notes: anumber of cases occurring in regions numbered from 1 to 13. breference 
is the comparison region, and can be used for comparison with other regions and to 
calculate IRR. There are no significant differences between regions, P-value .0.05, 
*P-value ,0.05.
Abbreviations: IRR, incidence rate ratio; CI, confidence interval.
Table 4 segi (world) standard for making comparisons with 
intermediate-age population (segi, 1960)
Age group Segi (world) standard
0–4 12,000
5–9 10,000
10–14 9,000
15–19 9,000
20–24 8,000
25–29 8,000
30–34 6,000
35–39 6,000
40–44 6,000
45–49 6,000
50–54 5,000
55–59 4,000
60–64 4,000
65–69 3,000
70–74 2,000
75+ 2,000
Total 100,000
Note: The segi (world) standard can be used in direct method of standardization 
to calculate the asIr and asMr. asIr is a technique used to compare the incidence 
rates among different populations when the confounding variable is age. asMr is a 
technique used to compare mortality rates among different populations when the 
confounding variable is age.
Abbreviations: asIr, age-standardized incidence rate; asMr, age-standardized 
mortality rate.
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focused on the CIR and ASIR of ovarian cancer in  different 
regions of Saudi Arabia from 2001–2008. To the best of our 
knowledge, this is the first geographical descriptive epide-
miological study of ovarian cancer cases in Saudi Arabia. 
It presents the pattern and the trend of the disease from 
2001–2008. In addition, this study provides an important 
explanation for the observed trend, thereby highlighting the 
significance of this disease.
The results indicated that the regions of Riyadh, Jouf, 
and Asir had the highest overall ASIRs for ovarian cancer in 
Saudi Arabia from 2001–2008; however, the overall ASIRs 
of these regions did not increase above the expected levels. In 
contrast, the regions of Jazan and Hail had the lowest overall 
ASIRs of ovarian cancer in Saudi Arabia from 2001–2008. 
Women .44 years of age were the most affected by ovarian 
cancer in the different provinces of Saudi Arabia. Further-
more, the Poisson regression showed that the IRR of ovarian 
cancer cases in the regions of Riyadh and Makkah was more 
than six times higher than the reference region of Jazan.
This study also reported the changes in the percentage 
of ovarian cancer cases diagnosed, CIR, and ASIR from 
2001–2008. The Baha region had the largest differences in 
CIR and ASIR, which were both higher than their predicted 
values for the years 2001–2008. These differences in rates 
suggest that, from 2001–2008, more women in the region 
of Baha were affected by ovarian cancer than predicted. In 
contrast, the rates of ovarian cancer decreased in the regions 
of Najran and Hail. These regions reported the lowest changes 
in the respective study outcomes, with a downtrend observed 
in the CIR and ASIR from 2001–2008.
However, with the exception of the SCR reports, only 
limited information was available on the incidence of ovarian 
cancer in Saudi Arabia. This study intended to explore the 
real pattern of ovarian cancer in different regions of Saudi 
Arabia from 2001–2008. The findings of this study may be 
useful for researchers and decision makers in the field of 
medicine and health care administration in Saudi Arabia as 
they can provide opportunities for generating hypotheses 
about the potential risk factors of ovarian cancer in the highest 
affected regions. Furthermore, the findings can be utilized 
to conduct analytical epidemiological studies that aim to 
identify the relationship between exposure and disease.13 The 
availability of data from the SCR reports can also encourage 
further descriptive epidemiological studies of other types of 
cancers among the Saudi population.
Conclusion
The epidemiological analysis of the reports by the SCR, from 
2001–2008, revealed that the CIR and ASIR of ovarian cancer 
were increasing slightly. The regions of Riyadh, Jouf, and 
Asir had the highest overall ASIR in Saudi Arabia, while 
Jazan and Hail recorded the lowest rates. The IRR of ovarian 
cancer cases indicated a concern in the number of ovarian 
cancer cases diagnosed in certain regions, such as Makkah, 
Riyadh, and the eastern region of Saudi Arabia. Moreover, the 
region of Baha documented the greatest changes in CIR and 
ASIR from 2001–2008, while the regions of Najran and Hail 
reported the lowest. Nonetheless, further analytical studies 
are required to determine and to explore the potential risk 
factors of ovarian cancer in Saudi Arabia.
Table 6 Differences in the percentage, cIr, and asIr of ovarian cancer cases in the regions of saudi arabia from 2001–2008
Regions Percentage % CIR per 100,000 ASIR per 100,000
2008 2001 Difference 2008 2001 Difference 2008 2001 Difference
asir 4.7 4.0 0.7 1.9 0.9 0.9 3.0 1.7 1.3
Baha 8.8 2.5 6.4 3.3 0.4 2.9a 4.2 0.6 3.6a
Jazan 2.0 2.5 −0.5 0.5 0.3 0.2 1.1 0.4 0.7
Madinah 3.6 6.5 −2.9 1.6 1.7 −0.1 2.6 3.7 −1.1
Hail 2.2 5.1 −2.9 0.8 1.3 −0.5 1.2 2.3 −1.1
Qassim 2.6 1.4 1.2 1.1 0.5 0.6 2.0 0.9 1.1
riyadh 4.0 3.6 0.4 2.5 1.8 0.7 4.5 3.8 0.7
Makkah 3.8 3.1 0.7 2.1 1.0 1.1 3.5 1.5 1.5
najran 1.5 6.8 −5.8 0.5 1.8 −1.3 1.1 5.2 −4.1
Jouf 3.2 3.6 −0.4 1.2 0.5 0.7 2.8 3.3 −0.5
Tabuk 2.4 2.5 −0.1 0.9 0.8 0.1 1.9 1.1 0.8
eastern region 2.2 3.8 −1.6 1.3 1.6 −0.3 2.1 3.2 −1.1
northern region 1.9 0.0 1.9 0.8 0.0 0.8 1.3 0.0 1.3
Note: Values in bold denote the differences in the percentages, cIrs and asIrs of ovarian cancer cases between 2001 and 2008 in different regions of saudi arabia. aFor cIr 
and asIr, the region of Baha showed the greatest changes compared to other provinces of saudi arabia, P-value ,0.05.
Abbreviations: cIr, crude incidence rate; asIr, age-standardized incidence rate.
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